The interferon-induced murine Mxl protein, which is localized in the nucleus, most likely specifically blocks influenza virus replication by inhibiting nuclear viral mRNA synthesis, including the mRNA synthesis catalyzed by inoculum (parental) virion nucleocapsids (R. M. Krug, M. Shaw, B. Broni, G. Shapiro, and 0. Haller, J. Virol. 56:201-206, 1985). We tested two possible mechanisms for this inhibition. First, we determined whether the transport of parental nucleocapsids into the nucleus was inhibited in murine cells expressing the nuclear Mxl protein. (15, 23, 32) . This synthesis is initiated by host cell primers, specifically, capped (m7GpppNm-containing) RNA fragments derived from host cell RNA polymerase II transcripts (4, 22, 23, 30) . These host cell primers are generated by a viral cap-dependent endonuclease that cleaves the capped cellular RNAs 10 to 13 nucleotides from their 5' ends, preferentially at a purine residue. Viral mRNA synthesis is catalyzed by viral nucleocapsids, which consist of each of the eight virion RNAs associated with four viral proteins: the nucleocapsid (NP) protein and the three polymerase (P) 6335 on July 7, 2017 by guest
The interferon (IFN)-induced murine Mxl protein mediates selective resistance to influenza virus (12, 23, 34) . Only mouse cells possessing this Mx-positive allele develop an efficient antiviral state against influenza virus after exposure to alpha/beta interferon (IFN-a/o), whereas the antiviral state against other viruses is independent of the Mx gene (13) . The murine Mxl gene product is a 72-kDa protein that accumulates in the nucleus (8, 19) . The antiviral activity of the Mx protein does not require other IFN-induced proteins: when the cloned DNA encoding the murine Mxl protein was transfected into Mx-negative mouse 3T3 cells, an antiviral state specifically directed against influenza virus was established (35) .
A key issue is the determination of the mechanism by which the Mx protein selectively inhibits the replication of influenza viruses. Two studies have established that influenza virus mRNA synthesis catalyzed by the parental (inoculum) viral transcriptase, i.e., primary transcription, is severely inhibited in Mx-expressing cells. For Mx-positive mouse embryo cells treated with IFN-a/,B, it was shown that the steady-state levels of the viral mRNAs as well as the rate of viral mRNA synthesis per se, as measured by in vitro RNA synthesis catalyzed by permeabilized cells, were strongly inhibited (24) . In contrast, IFN treatment of Mxnegative mouse embryo cells had little or no effect on either the steady-state level or the rate of synthesis of viral mRNA made by the inoculum transcriptase. These observations were confirmed by studies of rat cells. Homologs to the murine Mxl protein have been identified in several other species (1, 16-18, 26, 27, 33) , and direct evidence has been obtained that the antiviral state induced by IFN-o/J against influenza virus in rat cells is mediated by an Mx-related protein (3) . Nuclear as well as cytoplasmic Mx homologs have been identified in rat cells, and as in Mx-positive mouse embryo cells, IFN-oc/1 treatment caused a severe inhibition in the accumulation of viral mRNAs synthesized by the parental viral transcriptase (26) .
Influenza virus mRNA synthesis occurs in the nucleus (15, 23, 32) . This synthesis is initiated by host cell primers, specifically, capped (m7GpppNm-containing) RNA fragments derived from host cell RNA polymerase II transcripts (4, 22, 23, 30) . These host cell primers are generated by a viral cap-dependent endonuclease that cleaves the capped cellular RNAs 10 to 13 nucleotides from their 5' ends, preferentially at a purine residue. Viral mRNA synthesis is catalyzed by viral nucleocapsids, which consist of each of the eight virion RNAs associated with four viral proteins: the nucleocapsid (NP) protein and the three polymerase (P) 6336 NOTES proteins (PB1, PB2, and PA) (20, 23, 36 4) , and a 100-,Ll aliquot was immunoprecipitated with protein A-Sepharose beads precoated with 5 ,ul of the anti-fusion protein antiserum by a procedure described previously (2) , and then the immunoprecipitate was analyzed on the same gel (lanes 5 to 8). Molecular masses are indicated in kilodaltons on the right.
provided by Robert Webster [37] ) and of a rhodamineconjugated second antibody (1:25 dilution). To ensure that we were detecting only those NP protein molecules that were associated with parental viral nucleocapsids, infection of Mx-positive cells was carried out in the presence of the protein synthesis inhibitor anisomycin, which was added 30 min before infection. No detectable synthesis of NP protein occurred under these conditions (Fig. 2) . Consequently, the only NP protein molecules in the infected cells were those associated with parental viral nucleocapsids. In Mx-positive cells not treated with IFN, this immunofluorescence procedure clearly detected parental viral nucleocapsids, which were predominantly in the nucleus (Fig. 3d) . The detection of parental nucleocapsids was dependent on the use of high concentrations of NP antibodies. Higher dilutions of the NP antisera, which readily detected the NP protein synthesized in the absence of anisomycin, failed to detect parental nucleocapsids.
Mx protein in Mx-positive cells treated with IFN was identified by using the rabbit polyclonal antibody generated against the CheY-Mx fusion protein expressed in E. coli and then goat anti-rabbit antibody coupled to fluorescein (Fig.  3a) . There was little or no nonspecific cross-reactivity between the Mx and NP antisera: little or no rhodamine staining occurred with the NP antiserum in the absence of infection (Fig. 3c) (Fig. 3b) .
To determine whether the Mx protein inhibited the transport of parental nucleocapsids into the nucleus, Mx-positive A2G embryo fibroblasts treated with IFN were infected with influenza virus in the presence of anisomycin. Transcription catalyzed by the parental nucleocapsids was severely inhibited under these conditions (24) . Two hours postinfection, the presence of the Mx protein (Fig. 3c) and of the parental nucleocapsids (Fig. 3f) was determined by double immunofluorescence using rhodamine and fluorescein staining. All the cells expressing high levels of the Mx protein in the nucleus also contained parental virus nucleocapsids in the nucleus. The intensity of NP-specific rhodamine staining was indistinguishable from that observed in A2G cells not treated with IFN (Fig. 3e) (31) . We determined whether Mx-positive cells treated with IFN contained nuclear cap-binding activities not present in Mx-negative cells treated with IFN. As controls, Mx-positive and Mx-negative cells not treated with IFN were also analyzed. UV light-induced cross-linking was used to identify proteins in nuclear extracts from these cells that specifically interact with the cap structure on an mRNA molecule, alfalfa mosaic virus RNA 4, containing 32p label only in its cap structure (5, 36) . Purified virion nucleocapsids were also subjected to this cross-linking. After cross-linking took place, the samples were treated with pancreatic RNase and then analyzed on protein gels for the presence of 32p label in proteins.
In nuclear extracts from both Mx-positive and Mx-negative cells treated with IFN, seven proteins were consistently cross-linked to the labeled cap; these proteins had molecular masses of 115, 80, 65, 43, 30, 24, and 18 kDa ( A previous study identified two nuclear cap-recognizing proteins with molecular masses close to those of the 115-and 18-kDa proteins and showed that an 80-kDa cap-recognizing protein in nuclear preparations was a cytoplasmic contaminant, the translation initiation factor eIF-4B (31). Consequently, the 43-kDa protein, which was found almost totally in the nuclear fraction, is the only species of nuclear capbinding protein that has not been reported previously. In the assay whose results are shown in Fig. 4 IFN treatment (seen in darker exposures of Fig. 4, lanes 1  and 7) .
No consistent difference in the cross-linking patterns of IFN-treated Mx-positive and Mx-negative cells was observed (compare lanes 2 and 8 of Fig. 4 ). In particular, no cap-binding protein in the molecular mass range of the Mx protein (between the 65-and 80-kDa proteins) was detected in the IFN-treated Mx-positive cells, even when the protein gels were run for a longer time than those of Fig. 4 in order to achieve better resolution of the 65-to 80-kDa-molecularmass species. Mx protein was present in these nuclear extracts, as shown by immunoprecipitation of a [35S]methionine-labeled nuclear extract (Fig. 4, lane 18) .
Conclusions. Several possible mechanisms can be proposed for the inhibition of influenza virus mRNA synthesis by the IFN-induced murine Mxl protein. In the present study, we tested two possible mechanisms for this inhibition. First, we determined whether the transport of parental viral nucleocapsids into the nucleus is blocked. Influenza virus most likely enters cells by endocytosis in coated pits, leading to the subsequent release of the nucleocapsids into the cytoplasm via a hemagglutinin protein-mediated fusion reaction with lysosomal membranes (25) . How the parental viral nucleocapsids are subsequently transported from the cytoplasm to the nucleus has not yet been determined. We analyzed the transport of parental nucleocapsids into the nucleus by using indirect immunofluoresence with monoclonal antibodies directed against the viral NP protein. 15 ,ug of nuclear extract from Mx-positive cells (lanes 1 to 6), 15 ,ug of nuclear extract from Mx-negative cells (lanes 7 to 12), or 1 ,ug of purified influenza virion nucleocapsids (lanes 13 to 17). Nuclear extracts were prepared as described by Dignam et al. (7), and purified virion nucleocapsids were prepared from lysolecithin-treated virions as previously described (30 murine Mxl protein may differ in its mode of action from that of one of the human Mx homologs, the MxA protein. The murine Mxl protein, which is localized in the nucleus, selectively inhibits only influenza virus replication. Deletion of the nuclear localization signal of the murine Mxl protein greatly reduced its anti-influenza virus activity (28) . In contrast, the human MxA protein, which is localized in the cytoplasm, is less specific in that it inhibits the replication of not only influenza virus but also vesicular stomatitis virus (1, 29) .
